Abstract | OBJECTIVES: METHODS: Sprague-Dawley rats were divided into three groups: I- zoledronic acid (ZA, n = 10); II-ZA and teriparatide (ZA + TP, n = 10); III-control (n = 10). Osteonecrosis was induced by administering zoledronic acid to groups ZA and ZA + TP. A week after the injections, rats underwent extraction of the first left mandibular molar. Following a four week period, TP was administered to the ZA + TP group for 28 days. Upon killing, extraction sockets were examined clinically, radiologically and histopathologically. RESULTS: Clinical examination revealed necrotic bone exposure in none of the animals. MicroCT (µCT) examination showed that bone mineral density of the newly formed bone in the extraction socket was lower in the ZA group than in the ZA + TP group (p < 0.05). Histopathological examination revealed that only the ZA and ZA + TP groups developed osteonecrosis, and the osteonecrotic bone area in the ZA group was larger than that in the ZA + TP group (p < 0.05). Tartrate-resistant acid phosphatase ( TRAcP) enzyme histochemistry revealed that the number of detached and large osteoclasts were higher in the ZA group than in other groups, whereas the number of apoptotic osteoclasts in both ZA and ZA + TP groups were higher than in the control group (p < 0.05). CONCLUSIONS:
|
Authors | N Ersan, L J van Ruijven, A L J J Bronckers, V Olgaç, D Ilgüy, V Everts |
Journal | Dento maxillo facial radiology
(Dentomaxillofac Radiol)
Vol. 43
Issue 1
Pg. 20130144
( 2014)
ISSN: 0250-832X [Print] England |
PMID | 24170800
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Biomarkers
- Bone Density Conservation Agents
- Diphosphonates
- Imidazoles
- Isoenzymes
- Teriparatide
- Zoledronic Acid
- Acid Phosphatase
- Tartrate-Resistant Acid Phosphatase
|
Topics |
- Acid Phosphatase
(analysis)
- Alveolar Process
(drug effects, pathology)
- Animals
- Apoptosis
(drug effects)
- Biomarkers
(analysis)
- Bisphosphonate-Associated Osteonecrosis of the Jaw
(pathology, prevention & control)
- Bone Density
(drug effects)
- Bone Density Conservation Agents
(administration & dosage, adverse effects, therapeutic use)
- Bone Marrow
(drug effects, pathology)
- Cell Adhesion
(drug effects)
- Cell Count
- Diphosphonates
(administration & dosage, adverse effects, therapeutic use)
- Disease Models, Animal
- Female
- Imidazoles
(administration & dosage, adverse effects, therapeutic use)
- Injections, Intraperitoneal
- Injections, Subcutaneous
- Isoenzymes
(analysis)
- Molar
(surgery)
- Osteoclasts
(drug effects, pathology)
- Osteogenesis
(drug effects)
- Random Allocation
- Rats
- Rats, Sprague-Dawley
- Tartrate-Resistant Acid Phosphatase
- Teriparatide
(administration & dosage, therapeutic use)
- Tooth Extraction
- Tooth Socket
(drug effects, pathology)
- X-Ray Microtomography
- Zoledronic Acid
|